ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,143Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1454

$1.56M Total Retail Price of All Prescriptions

Rank: 21 out of 1454

603 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 603 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 603 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 21,037 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 1,021 843 1 6
OMEPRAZOLE 920 763 2 3
WARFARIN SODIUM 769 655 3 17
LISINOPRIL 732 648 4 4
POTASSIUM CHLORIDE 676 558 5 15
SIMVASTATIN 635 537 6 1
AMLODIPINE BESYLATE 585 526 7 2
DONEPEZIL HCL 581 529 8 29
LEVOTHYROXINE SODIUM 574 461 9 5
CITALOPRAM HBR 546 446 10 21
HYDROCODONE-ACETAMINOPHEN 476 395 S3 11 7
METOPROLOL TARTRATE 461 368 12 10
MIRTAZAPINE 444 364 13 53
NOVOLOG 429 304 14 99
SERTRALINE HCL 375 311 15 26
NAMENDA 347 311 16 48
LANTUS 345 230 17 51
GABAPENTIN 305 259 18 16
RANITIDINE HCL 272 219 19 43
TRAMADOL HCL 251 212 20 20
METOPROLOL SUCCINATE 237 226 21 13
CIPROFLOXACIN HCL 235 198 22 64
LEVOFLOXACIN 231 181 23 95
DIVALPROEX SODIUM 228 178 24 106
PRAVASTATIN SODIUM 210 178 25 12
NITROFURANTOIN MONO-MACRO 204 157 26 217
METOCLOPRAMIDE HCL 204 118 26 121
TRAZODONE HCL 200 146 28 50
PROMETHAZINE HCL 195 122 R 29 82
PREDNISONE 187 176 30 36
POLYETHYLENE GLYCOL 3350 183 147 31 61
CYMBALTA 181 134 32 55
TAMSULOSIN HCL 181 153 32 34
AMOX TR-POTASSIUM CLAVULANATE 178 142 34 148
FLUTICASONE PROPIONATE 167 126 35 30
METFORMIN HCL 164 115 36 8
LEVETIRACETAM 163 49 37 114
NEXIUM 163 135 37 23
CARVEDILOL 162 111 39 24
SULFAMETHOXAZOLE-TRIMETHOPRIM 161 132 40 108
ADVAIR DISKUS 161 151 40 47
CARBIDOPA-LEVODOPA 159 130 42 130
QUETIAPINE FUMARATE 156 105 43 91
ATORVASTATIN CALCIUM 154 119 44 11
EXELON 153 152 45 135
CEPHALEXIN 152 137 46 127
RISPERIDONE 150 120 47 86
ALLOPURINOL 148 129 48 28
ISOSORBIDE MONONITRATE ER 146 125 49 46
IPRATROPIUM-ALBUTEROL 143 129 50 151
GLIMEPIRIDE 139 111 51 33
PERMETHRIN 139 112 51 373
CLONIDINE HCL 138 121 53 49
GLIPIZIDE 133 133 54 62
SPIRIVA 129 110 55 52
VENLAFAXINE HCL ER 126 115 56 105
DIOVAN 126 126 56 40
NITROGLYCERIN PATCH 126 126 56 190
LOSARTAN POTASSIUM 125 114 59 14
KLOR-CON M10 122 93 60 145
DILTIAZEM 24HR ER 121 110 61 120
ATENOLOL 120 97 62 18
HYDRALAZINE HCL 115 107 63 67
FENTANYL 113 83 S2 64 104
CLOPIDOGREL 111 75 65 32
MELOXICAM 111 87 65 37
ZOLPIDEM TARTRATE 107 80 67 19
NYSTATIN 107 90 67 184
LOVASTATIN 106 94 69 39
DILANTIN 104 88 70 244
ESCITALOPRAM OXALATE 102 91 71 78
SEROQUEL 100 66 72 177
METFORMIN HCL ER 98 87 73 41
PANTOPRAZOLE SODIUM 94 81 74 31
CYCLOBENZAPRINE HCL 93 56 R 75 59
DIGOXIN 92 77 76 70
NOVOLIN N 92 57 76 261
MEGACE ES 90 83 R 78 344
AZITHROMYCIN 88 63 79 42
ROPINIROLE HCL 88 60 79 96
PLAVIX 83 70 81 45
JANUVIA 82 65 82 77
ALENDRONATE SODIUM 82 72 82 35
ALBUTEROL SULFATE 79 57 84 178
KLOR-CON M20 79 52 84 54
DOXYCYCLINE HYCLATE 78 61 86 110
NOVOLOG MIX 70-30 77 70 87 269
HUMALOG 77 45 87 153
FINASTERIDE 77 77 87 94
LEVEMIR 76 50 90 202
FLUOXETINE HCL 75 47 91 72
CRESTOR 73 56 92 22
LIDODERM 71 53 93 158
DILTIAZEM 24HR CD 70 61 94 76
SINGULAIR 70 56 94 83
PHENYTOIN SODIUM EXTENDED 68 64 96 138
CLINDAMYCIN HCL 68 60 96 282
SPIRONOLACTONE 67 48 98 63
HYDROCHLOROTHIAZIDE 65 62 99 9
GENTAMICIN SULFATE 65 58 99 290
OXYCODONE HCL 64 53 S2 101 80
TRIAMCINOLONE ACETONIDE 63 52 102 142
DILTIAZEM ER 62 54 103 126
LANSOPRAZOLE 62 39 103 140
LAMOTRIGINE 61 30 105 187
BENZTROPINE MESYLATE 60 55 R 106 174
OLANZAPINE 60 42 106 163
LACTULOSE 59 0 108 152
TIZANIDINE HCL 58 38 109 154
RISPERDAL CONSTA 58 27 109 357
VIMPAT 57 0 111 453
FLUCONAZOLE 57 44 111 160
FAMOTIDINE 57 28 111 88
OXYBUTYNIN CHLORIDE ER 57 57 111 156
BACLOFEN 56 31 115 146
PAROXETINE HCL 55 50 116 73
BUSPIRONE HCL 54 50 117 176
NYSTOP 52 34 118 245
PRIMIDONE 51 51 119 279
AGGRENOX 50 43 120 161
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.